The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Alifirova V.M.

Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Tomsk, Russia

Bakhtiiarova K.Z.

Bashkirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Ufa

Belova A.N.

Yaroslavl Regional Clinical Oncological Hospital, Yaroslavl, Russia

Bisaga G.N.

Voenno-meditsinskaia akademiia im. S.M. Kirova, klinika nervnykh bolezneĭ, Sankt-Peterburg;
Moskovskiĭ gorodskoĭ tsentr rasseiannogo skleroza

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Boĭko O.V.

Moskovskiĭ gorodskoĭ tsentr rasseiannogo skleroza na baze Gorodskoĭ klinicheskoĭ bol'nitsy #11

Vlasov Ia.V.

Kafedra nevrologii i neĭrokhirurgii Samarskogo gosudarstvennogo meditsinskogo universiteta

Volkova L.I.

Ural State Medical Academy, Ekaterinburg

Goncharova Z.A.

Rostovskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Rostov-na-Donu

Davydovskaya M.V.

Research and Practical Centre for Clinical Investigations and Evaluation of Medical Technologies, Moscow Health Department, Moscow, Russia

Zakharova M.N.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Kotov S.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Lashch N.Iu.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta

Malkova N.A.

Novosibirskiĭ okruzhnoĭ tsentr rasseiannogo skleroza

Petrov A.M.

Kafedra éndoskopicheskoĭ khirurgii fakul'teta poslediplomnogo obrazovaniia MGMSU

Popova E.V.

Kafedra nervnykh bolezneĭ fakul'teta poslevuzovskogo professional'nogo obrazovaniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Sivertseva S.A.

Tiumenskiĭ oblastnoĭ tsentr rasseiannogo skleroza

Sokolova I.A.

Nizhnii Novgorod

Spirin N.N.

Kafedra nervnykh bolezneĭ i meditsinskoĭ genetiki s kursom neĭrokhirurgii Iaroslavskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Stoliarov I.D.

Streknev A.G.

Saratov

Totolian N.A.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. I.P. Pavlova

Khachanova N.V.

Burdenko Neurosurgical Institute, Moscow, Russia

Sherman M.I.

Kirov

Shmidt T.E.

Kafedra nervnykh bolezneĭ Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova, Moskva

Khabirov F.A.

Kazanskaia gosudarstvennaia meditsinskaia akademiia Minzdravsotsrazvitiia Rossii;
Respublikanskiĭ kliniko-diagnosticheskiĭ tsentr po demieliniziruiushchim zabolevaniiam Ministerstva zdravookhraneniia Respubliki Tatarstan, Kazan'

Iampol'skaia-Gosteva I.A.

GBUZ "Orenburgskaia oblastnaia klinicheskaia bol'nitsa", Orenburg

Clinical recommendations on the use of teriflunomide

Authors:

Alifirova V.M., Bakhtiiarova K.Z., Belova A.N., Bisaga G.N., Boĭko A.N., Boĭko O.V., Vlasov Ia.V., Volkova L.I., Goncharova Z.A., Davydovskaya M.V., Zakharova M.N., Kotov S.V., Lashch N.Iu., Malkova N.A., Petrov A.M., Popova E.V., Sivertseva S.A., Sokolova I.A., Spirin N.N., Stoliarov I.D., Streknev A.G., Totolian N.A., Khachanova N.V., Sherman M.I., Shmidt T.E., Khabirov F.A., Iampol'skaia-Gosteva I.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(10‑2): 98‑104

DOI: 10.17116/jnevro201611610298-104

Views: 10198

Downloaded: 197

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Alifirova VM, Bakhtiiarova KZ, Belova AN, et al. . Clinical recommendations on the use of teriflunomide. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(10‑2):98‑104. (In Russ.)
https://doi.org/10.17116/jnevro201611610298-104

 
МСФ на ЯМ
Close metadata

Authors:

Alifirova V.M.

Sibirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Tomsk, Russia

Bakhtiiarova K.Z.

Bashkirskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Ufa

Belova A.N.

Yaroslavl Regional Clinical Oncological Hospital, Yaroslavl, Russia

Bisaga G.N.

Voenno-meditsinskaia akademiia im. S.M. Kirova, klinika nervnykh bolezneĭ, Sankt-Peterburg;
Moskovskiĭ gorodskoĭ tsentr rasseiannogo skleroza

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Boĭko O.V.

Moskovskiĭ gorodskoĭ tsentr rasseiannogo skleroza na baze Gorodskoĭ klinicheskoĭ bol'nitsy #11

Vlasov Ia.V.

Kafedra nevrologii i neĭrokhirurgii Samarskogo gosudarstvennogo meditsinskogo universiteta

Volkova L.I.

Ural State Medical Academy, Ekaterinburg

Goncharova Z.A.

Rostovskiĭ gosudarstvennyĭ meditsinskiĭ universitet, Rostov-na-Donu

Davydovskaya M.V.

Research and Practical Centre for Clinical Investigations and Evaluation of Medical Technologies, Moscow Health Department, Moscow, Russia

Zakharova M.N.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Kotov S.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Lashch N.Iu.

Kafedra nevrologii i neĭrokhirurgii Rossiĭskogo natsional'nogo issledovatel'skogo meditsinskogo universiteta

Malkova N.A.

Novosibirskiĭ okruzhnoĭ tsentr rasseiannogo skleroza

Petrov A.M.

Kafedra éndoskopicheskoĭ khirurgii fakul'teta poslediplomnogo obrazovaniia MGMSU

Popova E.V.

Kafedra nervnykh bolezneĭ fakul'teta poslevuzovskogo professional'nogo obrazovaniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Sivertseva S.A.

Tiumenskiĭ oblastnoĭ tsentr rasseiannogo skleroza

Sokolova I.A.

Nizhnii Novgorod

Spirin N.N.

Kafedra nervnykh bolezneĭ i meditsinskoĭ genetiki s kursom neĭrokhirurgii Iaroslavskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Stoliarov I.D.

Streknev A.G.

Saratov

Totolian N.A.

Sankt-Peterburgskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. akad. I.P. Pavlova

Khachanova N.V.

Burdenko Neurosurgical Institute, Moscow, Russia

Sherman M.I.

Kirov

Shmidt T.E.

Kafedra nervnykh bolezneĭ Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova, Moskva

Khabirov F.A.

Kazanskaia gosudarstvennaia meditsinskaia akademiia Minzdravsotsrazvitiia Rossii;
Respublikanskiĭ kliniko-diagnosticheskiĭ tsentr po demieliniziruiushchim zabolevaniiam Ministerstva zdravookhraneniia Respubliki Tatarstan, Kazan'

Iampol'skaia-Gosteva I.A.

GBUZ "Orenburgskaia oblastnaia klinicheskaia bol'nitsa", Orenburg

List of references:

  1. Leist T, Freedman MS, Kappos L et al. Pooled safety data from three placebo-controlled teriflunomide studies. Mult Scler. 2013;19:74:633.
  2. Bar-Or A, Freedman MS, Kremenchutzky M et al. Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis. Neurology. 2013;81:552-558.
  3. Claussen MC, Korn T. Immune mechanisms of new therapeutic strategies in MS: teriflunomide. Clin Immunol. 2012;142:49-56.
  4. Li L, Liu J, Delohery T et al. The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro. J Neuroimmunol. 2013;265:82-90.
  5. Limsakun T, Menguy-Vacheron F. Pharmacokinetics of oral teriflunomide, a novel oral disease-modifiying agent under investigation for the treatment of MS. Presented at the Annual Meeting of the American Academy of Neurology (AAN); April 15, 2010; Toronto.
  6. Tallantyre E, Evangelou N, Constantinescu CS Spotlight on teriflunomide. The International MS Journal. 2008;15:62-68.
  7. Wang L, Van Horn R, Turpault S et al. Metabolism comparison between leflunomide and teriflunomide in humans. Eur J Neurol. 2011;18(suppl 2):268. A-369-0016-00591.
  8. Freedman MS, O'Connor PW, Li D. A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. Neurology. 2006;66(6):894-900.
  9. Confavreux C, Li DK, Freedman MS. Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years. Mult Scler. 2012;18(9):1278-1289.
  10. O’Connor, Wolinsky J, Confavreux C et al. Randomized trial of oral teriflunomide for relapsing multiple sclerosis. The New England Journal of Medicine. 2011;365:1293-1303.
  11. Confavreux C, O’Connor P, Comi G et al. Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2014;13(3):247-256.
  12. Vermersch P. Phase III head to head comparison study of teriflunomide and interferon beta-1a (TENERE). Presented at European Neurological Society. 2012;427.
  13. Kieseier B. Teriflunomide and pregnancies. Presented at PACTRIMS. 2013:79.
  14. Harrison S, Bergfeld W. Diffuse hair loss: its triggers and management. Cleve Clin J Med. 2009;76(6):361-367.
  15. Dörr J, Paul F. The transition from first-line to second-line therapy in multiple sclerosis. Curr Treat Options Neurol. 2015;17(6):354-358.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.